Company Filing History:
Years Active: 2017
Title: Mattieu Montes: Innovator in Pharmaceutical Composition
Introduction
Mattieu Montes is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of chronic colitis and systemic sclerosis. His innovative approach focuses on eliciting a protective immune reaction against human IL-6.
Latest Patents
Montes holds a patent for a method that involves a pharmaceutical composition comprising at least one polypeptide. This polypeptide consists of a sequence of at least 8 contiguous amino acids, chosen from within the interleukin-6 sequence, and from at most 30 contiguous amino acids from the complete IL-6 sequence. This invention aims to provide a new therapeutic avenue for patients suffering from chronic inflammatory conditions.
Career Highlights
Mattieu Montes is associated with Peptinov Sas, a company dedicated to advancing peptide-based therapies. His work has been instrumental in developing innovative solutions that address complex medical challenges. With a patent portfolio that includes 1 patent, Montes continues to push the boundaries of pharmaceutical research.
Collaborations
Montes collaborates with esteemed colleagues such as Lucille Desallais and Jean-Francois Zagury. Their combined expertise fosters a dynamic research environment that enhances the development of novel therapeutic strategies.
Conclusion
Mattieu Montes exemplifies the spirit of innovation in the pharmaceutical industry. His contributions are paving the way for new treatments that could significantly improve patient outcomes.